The potential of nanotechnology to combat the Covid-19 pandemic

In March 2020, the World Health Organization (WHO) announced that Coronavirus (2019) (COVID-19) was recognized as a global epidemic. In late 2019, a new type of the coronavirus family, known as Acute Respiratory Syndrome (SARS-CoV-2), emerged in Wuhan, China, and was named Covid-19. The COVID-19 epidemic has plunged the world into an unprecedented crisis, causing huge human and economic losses. As of July 6, 2020. The high rate of lung infection, long latency period, with mild to moderate symptoms or even cases that many people experience, or even cases of asymptomatic patients, has made Covid-19 a worrying disease. Challenges to treat the disease include vaccine design, high-speed mass production, and uniform worldwide distribution. Nanoparticles with their physicochemical properties can be a promising treatment method to win the battle against coronaviruses. Nanotechnology usually deals with the design and development of materials with dimensions of 1 nanometer to hundreds of nanometers, which makes it possible to design and manufacture materials with the desired structure and a controllable and small structure. In this review article, we explore the disease of Covid-19 and the potential of nanotechnology as a bright and promising pathway for the diagnosis, drug delivery, and treatment of Covid-19.